245 related articles for article (PubMed ID: 36224639)
21. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
[TBL] [Abstract][Full Text] [Related]
22. Adipose-Tumor Crosstalk contributes to CXCL5 Mediated Immune Evasion in PDAC.
Walsh RM; Ambrose J; Jack JL; Eades AE; Bye B; Ruckert MT; Olou AA; Messaggio F; Chalise P; Pei D; VanSaun MN
bioRxiv; 2023 Aug; ():. PubMed ID: 37645755
[TBL] [Abstract][Full Text] [Related]
23. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.
Li Z; Zhou J; Zhang J; Li S; Wang H; Du J
Int J Cancer; 2019 Oct; 145(7):1946-1957. PubMed ID: 30873585
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
Li A; King J; Moro A; Sugi MD; Dawson DW; Kaplan J; Li G; Lu X; Strieter RM; Burdick M; Go VL; Reber HA; Eibl G; Hines OJ
Am J Pathol; 2011 Mar; 178(3):1340-9. PubMed ID: 21356384
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo.
Yoneda T; Kunimura N; Kitagawa K; Fukui Y; Saito H; Narikiyo K; Ishiko M; Otsuki N; Nibu KI; Fujisawa M; Serada S; Naka T; Shirakawa T
Cancer Gene Ther; 2019 Nov; 26(11-12):388-399. PubMed ID: 30607005
[TBL] [Abstract][Full Text] [Related]
27. Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.
Takao A; Yoshikawa K; Karnan S; Ota A; Uemura H; De Velasco MA; Kura Y; Suzuki S; Ueda R; Nishino T; Hosokawa Y
Oncol Rep; 2018 Nov; 40(5):2455-2466. PubMed ID: 30226608
[TBL] [Abstract][Full Text] [Related]
28. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
29. Gα-13 induces C
Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression.
Kuo PL; Huang MS; Hung JY; Chou SH; Chiang SY; Huang YF; Yang CJ; Tsai MJ; Chang WA; Hsu YL
Int J Cancer; 2014 Jul; 135(1):96-108. PubMed ID: 24346967
[TBL] [Abstract][Full Text] [Related]
31. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun.
Riedel M; Berthelsen MF; Cai H; Haldrup J; Borre M; Paludan SR; Hager H; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
Oncogene; 2021 Apr; 40(13):2437-2447. PubMed ID: 33674748
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
33. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
34. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
35. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ
Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852
[TBL] [Abstract][Full Text] [Related]
36. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
38. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
39. CXCL5 promotes prostate cancer progression.
Begley LA; Kasina S; Mehra R; Adsule S; Admon AJ; Lonigro RJ; Chinnaiyan AM; Macoska JA
Neoplasia; 2008 Mar; 10(3):244-54. PubMed ID: 18320069
[TBL] [Abstract][Full Text] [Related]
40. IL-10-overexpressing B cells regulate innate and adaptive immune responses.
Stanic B; van de Veen W; Wirz OF; Rückert B; Morita H; Söllner S; Akdis CA; Akdis M
J Allergy Clin Immunol; 2015 Mar; 135(3):771-80.e8. PubMed ID: 25240783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]